Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleNeuropharmacology

Intrathecal Intermittent Orexin-A Causes Sympathetic Long-Term Facilitation and Sensitizes the Peripheral Chemoreceptor Response to Hypoxia in Rats

Seung Jae Kim, Paul M. Pilowsky and Melissa M. J. Farnham
Journal of Pharmacology and Experimental Therapeutics September 2016, 358 (3) 492-501; DOI: https://doi.org/10.1124/jpet.116.234443
Seung Jae Kim
Department of Physiology, Sydney Medical School, University of Sydney, and Heart Research Institute, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Seung Jae Kim
Paul M. Pilowsky
Department of Physiology, Sydney Medical School, University of Sydney, and Heart Research Institute, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul M. Pilowsky
Melissa M. J. Farnham
Department of Physiology, Sydney Medical School, University of Sydney, and Heart Research Institute, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Melissa M. J. Farnham
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Effect of intrathecal orexin-A at (A) subthreshold bolus (100 pmol)/intermittent (10 pmol × 10) and (B) suprathreshold bolus (20 nmol)/intermittent (2 nmol × 10) doses in a urethane-anesthetized rat on (from the top) HR (beats per minute), MAP (mm Hg), and sSNA (µV). Time of administration of intrathecal orexin-A (both single and intermittent) are indicated by the arrow(s). Note that intermittent subthreshold (10 pmol) orexin-A causes the generation of sympathetic long-term facilitation.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    A comparison of the sympathoexcitatory response elicited by bolus versus intermittent orexin-A at both (A) suprathreshold and (B) subthreshold doses. Single administration of orexin-A (100 pmol; n = 4) and orexin-A (100 pmol) + Almorexant (AXT) at 75 mg⋅kg−1 (n = 5) did not elevate sympathetic activity. (C) No significant changes were observed compared with PBS control (n = 5) when sSNA is measured as % range. Grouped data for the % range from every treatment group are compared. AXT at 75 mg⋅kg−1 (n = 4) produced no effect on baseline sympathetic activity. (D) AXT at 30 mg⋅kg−1 (n = 5) and 75 mg⋅kg−1 (n = 5) attenuated the effect of intermittent orexin-A (10 pmol × 10; n = 5) on sSNA. Statistical significance was determined using one-way analysis of variance followed by Holm-Sidak correction to compare the effects with the control. Data are expressed as mean ± S.E.M. ****P < 0.0001; ***P < 0.001; *P < 0.05. #P < 0.05 compared with intermittent orexin-A (10 pmol × 10).

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    In vivo effects of acute intermittent hypoxia (AIH, 10 bouts of 10% oxygen interspersed by 5-minute intervals) and intraperitoneal injection of Almorexant (AXT). (A) Experimental trace displaying the effect of AXT 30 mg⋅kg−1 (n = 5) in AIH, recording the changes in electrocardiogram (ECG), HR, MAP, phrenic nerve activity (PNA), and sSNA. Blood gas was analyzed at 30 and 60 minutes after AIH as indicated by the arrows. A 10-minute recording of pre-AIH sSNA and post-AIH sSNA is referred by the expanded period as indicated. (B) Comparison between the change in sSNA between PBS-treated AIH (n = 6) and DMSO-treated AIH (n = 5). All AXT-treated groups are compared with the DMSO-treated AIH group, where both AXT 30 mg⋅kg−1 and 75 mg⋅kg−1 (n = 5) AXT injections were made 10 minutes before AIH. (C) Change in sSNA shown as % range. Statistical significance was determined using one-way analysis of variance followed by Holm-Sidak correction. Data are expressed as mean ± S.E.M.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Difference in the AUC between the initial and final sympathetic responses to hypoxia-induced chemoreceptor activation. The net AUC difference in the sympathetic response to hypoxia was identified for the baseline activity and the response at 60 minutes after treatment: intermittent orexin-A or acute intermittent hypoxia (AIH). (A) The value for the net difference in AUC (final minus initial hypoxia) compared for the treatments groups involving PBS (n = 5), intermittent orexin-A 10 pmol × 10 (n = 5), and Almorexant (AXT) at 30 (n = 5) and 75 mg⋅kg−1 (n = 5). (B) Similarly, net difference in AUC between the baseline and final sympathetic response to hypoxia after AIH + PBS (n = 6), AIH + DMSO (n = 5), AIH + AXT 30 mg⋅kg−1 (n = 5), and AIH + AXT 75 mg⋅kg−1 (n = 5). For grouped data, statistical significance was determined using one-way analysis of variance followed by multiple comparisons with a Holm-Sidak correction to compare the effects with the control. All values are expressed as mean ± S.E.M. ***P < 0.005 for significance. ##P < 0.01 and ####P < 0.0001 compared with intermittent orexin-A (10 pmol × 10).

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Sympathetic outflow from hypoxia-induced peripheral chemoreceptor activation requires a contribution from hypothalamic orexin neurons. Hypoxia directly activates the peripheral chemoreceptors of the carotid body, which sends afferent excitatory signals to the brainstem medulla. The nerves synapse to the nucleus tractus solitarii (NTS), which excite the rostral ventrolateral medulla (RVLM) nerves and further relay these signals to the intermediolateral (IML) of the spinal T5/6 level. Simultaneously, orexin neurons are excited by repetitive hypoxia. Both orexin receptor subtypes (OX1R and OX2R) are found on SPNs in the intermediolateral and are necessary to sensitize the sympathetic chemoreflex response to hypoxia.

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 358 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 358, Issue 3
1 Sep 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Intrathecal Intermittent Orexin-A Causes Sympathetic Long-Term Facilitation and Sensitizes the Peripheral Chemoreceptor Response to Hypoxia in Rats
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleNeuropharmacology

Prolonged Sympathoexcitation by Repetitive Orexin-A

Seung Jae Kim, Paul M. Pilowsky and Melissa M. J. Farnham
Journal of Pharmacology and Experimental Therapeutics September 1, 2016, 358 (3) 492-501; DOI: https://doi.org/10.1124/jpet.116.234443

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleNeuropharmacology

Prolonged Sympathoexcitation by Repetitive Orexin-A

Seung Jae Kim, Paul M. Pilowsky and Melissa M. J. Farnham
Journal of Pharmacology and Experimental Therapeutics September 1, 2016, 358 (3) 492-501; DOI: https://doi.org/10.1124/jpet.116.234443
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • P-Glycoprotein Apical Efflux Ratio for Compound Optimization
  • Pharmacology of Carbamate Insecticides at Melatonin Receptors
  • Metalloporphyrins modify disease outcomes in parkinsonism
Show more Neuropharmacology

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics